Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
Recent Posts
The Law Bytes Podcast, Episode 264: Jon Penney on Chilling Effects in the Digital Age 
Heads They Win, Tails We Lose: What Lies Behind the U.S. Trade Battle For Control over Data 
Still Not a Privacy Law: Bill C-25’s Political Party Privacy Provisions Fall Short Again 
Could Bill C-22 Make Canadians Less Safe? The Systemic Vulnerability Gap in Canada’s New Surveillance Law 
Why the Verdict on Social Media Defective Design Harming Children Gets the Instinct Right But the Law Wrong
